These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 24480486)

  • 1. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral atrophy in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Martí MJ; Tolosa E; Giménez M; Bargalló N; Valldeoriola F; Junqué C
    Eur J Neurol; 2007 Jul; 14(7):750-6. PubMed ID: 17594330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson's disease.
    Bejr-Kasem H; Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Eur J Neurol; 2021 Feb; 28(2):438-447. PubMed ID: 33032389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2010 Apr; 25(5):615-22. PubMed ID: 20175186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease.
    Shin S; Lee JE; Hong JY; Sunwoo MK; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Dec; 83(12):1155-61. PubMed ID: 22933812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's disease.
    Zarkali A; McColgan P; Leyland LA; Lees AJ; Weil RS
    J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):169-179. PubMed ID: 34583941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies.
    Ibarretxe-Bilbao N; Junque C; Marti MJ; Tolosa E
    J Neurol Sci; 2011 Nov; 310(1-2):79-81. PubMed ID: 21705027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; de Jong BM; Renken R; Leenders KL; Cornelissen FW; van Laar T
    Brain; 2009 Nov; 132(Pt 11):2980-93. PubMed ID: 19755518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations.
    Ibarretxe-Bilbao N; Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Bargallo N; Juanes S; Tolosa E
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):650-7. PubMed ID: 19965847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
    Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis.
    Gama RL; Bruin VM; Távora DG; Duran FL; Bittencourt L; Tufik S
    Brain Cogn; 2014 Jun; 87():97-103. PubMed ID: 24732953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's disease.
    Pezzoli S; Cagnin A; Antonini A; Venneri A
    Postgrad Med; 2019 Sep; 131(7):509-522. PubMed ID: 31422718
    [No Abstract]   [Full Text] [Related]  

  • 18. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease.
    de Schipper LJ; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
    Neuroimage Clin; 2017; 15():587-593. PubMed ID: 28652971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.